Womens Health
-
The PrimerFDA and Mifepristone: Regulatory Battles Over Abortion Pill Access and Safety
Sep 28, 2026
Explore the complex legal and regulatory debates surrounding the FDA's approval and evolving policy on mifepristone, the abortion pill central to nationwide controversies.
-
PoliticsWomen Urge Trump FDA Nominee to Reinstate Abortion Pill Safeguards
Sep 27, 2026
Three women who regret taking mifepristone are calling on Dr. Heidi Overton, Trumpβs FDA nominee, to restore in-person dispensing requirements for the abortion pill.
-
OpinionDebate Over Fertility Care and Women's Autonomy Intensifies
Nov 21, 2025
A recent opinion piece in The New York Times has sparked a debate about women's reproductive choices and the cultural implications of fertility care. Ruxandra.
-
OpinionPro-Abortion Culture Is Dangerous And Deadly For Women
Nov 5, 2025
Pro-abortion policies and the weakening of abortion safeguards are linked to significant harm for women and babies, with the consequences of a pro-abortion.
-
Courts & LawInaction On Abortion Pill Puts Women At Risk Of Harm, Abuse
Oct 28, 2025
However, the FDA recently approved a generic version of the drug, prompting further scrutiny from advocates who believe the current regulations are insufficient.
-
Health'Reproductive' Industry Hands Out Abortion Pills, Withholds Fertility Drugs
Oct 15, 2025
The reproductive health industry is facing criticism for its focus on abortion services while neglecting fertility treatments, particularly for older women.